Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to remarks at the BofA Annual Healthcare Conference. Bill Peters, chief financial officer of Amphastar

MarketBeat

Ormat Technologies Q1 Earnings Call Highlights

Ormat Technologies (NYSE:ORA) reported record first-quarter 2026 revenue and maintained its full-year outlook, as strength in its energy storage and product segments offset more modest growth in its electricity business. Chief Executive Officer Doron Blachar said the company began 2026 with “record

MarketBeat

OppFi Q1 Earnings Call Highlights

OppFi (NYSE:OPFI) reported higher first-quarter 2026 revenue but lower adjusted earnings as elevated charge-offs offset growth in receivables, while management emphasized a series of strategic moves aimed at reshaping the company into a broader technology-enabled banking platform. Executive Chairma

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

OR Royalties Q1 Earnings Call Highlights

OR Royalties (NYSE:OR) reported a record first quarter of 2026, with President and CEO Jason Attew saying the company is “off to an impressive start” as stronger production from its royalty and streaming portfolio combined with robust precious metals prices. The company earned 22,740 gold equivalen

MarketBeat

Optimum Communications Q1 Earnings Call Highlights

Optimum Communications (NYSE:OPTU) reported lower first-quarter revenue and a large net loss tied to a non-cash impairment charge, while executives said the company is leaning on simplified pricing, mobile growth, cost controls and balance-sheet actions to navigate an increasingly competitive broadb

MarketBeat

Montrose Environmental Group Q1 Earnings Call Highlights

Montrose Environmental Group (NYSE:ONT), now operating under the Onterris brand, reported lower first-quarter revenue as severe winter weather and reduced environmental emergency response activity weighed on results, but management reiterated its full-year outlook and pointed to stronger profitabili

MarketBeat

ON Q1 Earnings Call Highlights

ON (NYSE:ONON) reported what executives described as an “outstanding” start to 2026, with first-quarter net sales surpassing CHF 800 million for the first time and profitability expanding as the company reiterated its full-year growth outlook. Net sales reached CHF 831.9 million in the quarter, up

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Orion Office REIT Q1 Earnings Call Highlights

Orion Office REIT (NYSE:ONL) said its first-quarter results reflected continued progress on leasing, asset sales and balance-sheet management, while its board and management continue to evaluate strategic options with advisers Wells Fargo and JPMorgan. Chief Executive Officer Paul McDowell said the

MarketBeat

Infinity Natural Resources Q1 Earnings Call Highlights

Infinity Natural Resources (NYSE:INR) said its first quarter was marked by a significant expansion of its Appalachian footprint, following the late-February closing of its acquisition of Antero’s Ohio Utica assets and the addition of working interests in Pennsylvania through the Chase acquisition.

MarketBeat

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric hypoglycemia, or PBH, with data from the LUCIDITY trial expected in the third quarter, Co-Chief Executive Officer Joshua Cohen said at the BofA Annual Healthcare Conferenc

MarketBeat

Olin Q1 Earnings Call Highlights

Olin (NYSE:OLN) executives said the company expects a sharp sequential improvement in second-quarter earnings as higher pricing, seasonal demand and cost reductions begin to flow through results following a challenging but improving first quarter. Speaking on Olin’s first-quarter 2026 earnings call

MarketBeat

JBS Q1 Earnings Call Highlights

JBS (NYSE:JBS) reported record first-quarter sales but lower profitability as executives said the global protein company faced difficult market conditions in U.S. beef, seasonal pressures, operational adjustments and shifting trade flows. Global CEO Gilberto Tomazoni said the first quarter of 2026

MarketBeat

BTGO Q1 Earnings Call Highlights

BitGo (NYSE:BTGO) reported sharply higher first-quarter revenue from a year earlier but a wider GAAP loss, as executives said softer digital asset market conditions and accounting treatment for new derivatives activity made headline results less reflective of the company’s underlying business trends

MarketBeat

Doximity Q4 Earnings Call Highlights

Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Wrap Technologies Q1 Earnings Call Highlights

Wrap Technologies (NASDAQ:WRAP) said first-quarter revenue rose 45% year-over-year as product sales for its BolaWrap 150 line accelerated, while management reiterated its goal of doubling revenue in 2026. On the company’s first-quarter 2026 earnings call, Chief Executive Officer Scot Cohen said man

MarketBeat

USA Rare Earth Q1 Earnings Call Highlights

USA Rare Earth (NASDAQ:USAR) said its first quarter was marked by a series of strategic transactions intended to turn the company into a fully integrated rare earths platform spanning mining, processing, metals and magnet production. On the company’s first-quarter 2026 earnings call, Chief Executiv

MarketBeat

Energous Q1 Earnings Call Highlights

Energous (NASDAQ:WATT) reported sharply higher first-quarter revenue and a narrower loss as management said the wireless power company is moving from technology validation into commercial deployment across enterprise Internet of Things markets. On the company’s first earnings call since 2024, Chief

MarketBeat

STAAR Surgical Q1 Earnings Call Highlights

STAAR Surgical (NASDAQ:STAA) said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls following a difficult 2025. On the company’s earnings call, Interim Co-CEO, President and Chief Ope

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

QT Imaging Q1 Earnings Call Highlights

QT Imaging (NASDAQ:QTI) reported sharply higher first-quarter 2026 revenue as scanner shipments more than doubled from the prior-year period, while management highlighted progress on reimbursement, regulatory approvals, software upgrades and international expansion during the company’s earnings call

MarketBeat

Sangoma Technologies Q3 Earnings Call Highlights

Sangoma Technologies (NASDAQ:SANG) lowered its full-year fiscal 2026 revenue outlook and said its board has launched a structured strategic review, as management described a business increasingly split between growing communications infrastructure assets and more pressured software and UCaaS offerin

MarketBeat

Rapid Micro Biosystems Q1 Earnings Call Highlights

Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year. President and Chief

MarketBeat

Seer Q1 Earnings Call Highlights

Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and expected second-half consumables demand as supports for the year. Total revenue for the quarter ended

MarketBeat

Precigen Q1 Earnings Call Highlights

Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025. On the company’s earnings call, President and CEO Dr. Helen Sabzevari said PAPZIMEOS generated net pr

MarketBeat

Omeros Q1 Earnings Call Highlights

Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA. Chairman and Chief Executive

MarketBeat

MDxHealth Q1 Earnings Call Highlights

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic

1 … 18 19 20 21

People

Barbara Humpton

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.